Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jun;94(2):573–583. doi: 10.1111/j.1476-5381.1988.tb11563.x

Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat.

H Ruskoaho 1
PMCID: PMC1853997  PMID: 2840163

Abstract

1. The effects of atenolol (beta 1-adrenoceptor antagonist without partial agonistic activity) and pindolol (beta 1- and beta 2-antagonist with partial agonistic activity) were studied on basal coronary vascular tone and on the phorbol ester-induced coronary vasoconstriction in the rat perfused heart. 2. The addition of the phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA; 1.8 X 10(-8)-1.6 X 10(-7) M) into the perfusion fluid during perfusion of rat heart at constant flow caused a dose-dependent, sustained increase in perfusion pressure. The vasoconstrictor response in hearts of reserpine-treated rats to infusion of TPA was similar to that of non-reserpine treated hearts. 3. Infusion of a calcium channel agonist Bay K 8644 at a concentration of 4 X 10(-7) M enhanced, whereas isoprenaline (1 X 10(-5) M), dibuturyl-cyclic AMP (1.6 X 10(-4) M) and forskolin (1 X 10(-6) M), which elevate intracellular concentrations of cyclic AMP, all inhibited the coronary vasoconstriction induced by TPA. 4. Pindolol, in doses which produced comparable inhibition of isoprenaline-induced tachycardia, dose-dependently attenuated the phorbol ester-induced increase in perfusion pressure, whereas atenolol had no effect. The inhibitory action of pindolol (2 X 10(-5) M) on TPA-induced vasoconstriction was blocked by addition of 2.2 X 10(-5) M propranolol into the perfusion fluid. When infused alone, atenolol (2 X 10(-4) M) significantly increased coronary vascular tone, but pindolol had no effect. 5. The present results indicate that pindolol has coronary vasodilator properties due to stimulation of vascular beta-adrenoceptors. If stenosis dilatation of coronary artery spasm is an important component of the anti-anginal effect of beta-blocking drugs, the possession of partial agonistic property by a beta-blocking drug may be of importance in maintaining coronary flow.

Full text

PDF
573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berdeaux A., Giudicelli J. F. Intrinsic sympathomimetic activity and coronary blood flow. Br J Clin Pharmacol. 1982;13(Suppl 2):175S–180S. doi: 10.1111/j.1365-2125.1982.tb01907.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  3. Clark B. J., Menninger K., Bertholet A. Pindolol--the pharmacology of a partial agonist. Br J Clin Pharmacol. 1982;13(Suppl 2):149S–158S. doi: 10.1111/j.1365-2125.1982.tb01904.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Danthuluri N. R., Deth R. C. Phorbol ester-induced contraction of arterial smooth muscle and inhibition of alpha-adrenergic response. Biochem Biophys Res Commun. 1984 Dec 28;125(3):1103–1109. doi: 10.1016/0006-291x(84)91397-4. [DOI] [PubMed] [Google Scholar]
  5. Feigl E. O. Coronary physiology. Physiol Rev. 1983 Jan;63(1):1–205. doi: 10.1152/physrev.1983.63.1.1. [DOI] [PubMed] [Google Scholar]
  6. Feigl E. O. Sympathetic control of coronary circulation. Circ Res. 1967 Feb;20(2):262–271. doi: 10.1161/01.res.20.2.262. [DOI] [PubMed] [Google Scholar]
  7. Forder J., Scriabine A., Rasmussen H. Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction. J Pharmacol Exp Ther. 1985 Nov;235(2):267–273. [PubMed] [Google Scholar]
  8. Frishman W. H. Clinical differences between beta-adrenergic blocking agents: implications for therapeutic substitution. Am Heart J. 1987 May;113(5):1190–1198. doi: 10.1016/0002-8703(87)90933-1. [DOI] [PubMed] [Google Scholar]
  9. Gage J. E., Hess O. M., Murakami T., Ritter M., Grimm J., Krayenbuehl H. P. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation. 1986 May;73(5):865–876. doi: 10.1161/01.cir.73.5.865. [DOI] [PubMed] [Google Scholar]
  10. Gaglione A., Hess O. M., Corin W. J., Ritter M., Grimm J., Krayenbuehl H. P. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol. 1987 Aug;10(2):299–310. doi: 10.1016/s0735-1097(87)80011-6. [DOI] [PubMed] [Google Scholar]
  11. Itoh H., Lederis K. Contraction of rat thoracic aorta strips induced by phorbol 12-myristate 13-acetate. Am J Physiol. 1987 Feb;252(2 Pt 1):C244–C247. doi: 10.1152/ajpcell.1987.252.2.C244. [DOI] [PubMed] [Google Scholar]
  12. KLOCKE F. J., KAISER G. A., ROSS J., Jr, BRAUNWALD E. AN INTRINSIC ADRENERGIC VASODILATOR MECHANISM IN THE CORONARY VASCULAR BED OF THE DOG. Circ Res. 1965 Apr;16:376–382. doi: 10.1161/01.res.16.4.376. [DOI] [PubMed] [Google Scholar]
  13. Kern M. J., Ganz P., Horowitz J. D., Gaspar J., Barry W. H., Lorell B. H., Grossman W., Mudge G. H., Jr Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation. 1983 Jun;67(6):1178–1185. doi: 10.1161/01.cir.67.6.1178. [DOI] [PubMed] [Google Scholar]
  14. Miller J. R., Hawkins D. J., Wells J. N. Phorbol diesters alter the contractile responses of porcine coronary artery. J Pharmacol Exp Ther. 1986 Oct;239(1):38–42. [PubMed] [Google Scholar]
  15. Mudge G. H., Jr, Grossman W., Mills R. M., Jr, Lesch M., Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med. 1976 Dec 9;295(24):1333–1337. doi: 10.1056/NEJM197612092952401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986 Jul 18;233(4761):305–312. doi: 10.1126/science.3014651. [DOI] [PubMed] [Google Scholar]
  17. PARRATT J. R. BLOCKAGE OF SYMPATHETIC BETA-RECEPTORS IN THE MYOCARDIAL CIRCULATION. Br J Pharmacol Chemother. 1965 Jun;24:601–611. doi: 10.1111/j.1476-5381.1965.tb01616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pitt B., Elliot E. C., Gregg D. E. Adrenergic receptor activity in the coronary arteries of the unanesthetized dog. Circ Res. 1967 Jul;21(1):75–84. doi: 10.1161/01.res.21.1.75. [DOI] [PubMed] [Google Scholar]
  19. Rasmussen H., Forder J., Kojima I., Scriabine A. TPA-induced contraction of isolated rabbit vascular smooth muscle. Biochem Biophys Res Commun. 1984 Jul 31;122(2):776–784. doi: 10.1016/s0006-291x(84)80101-1. [DOI] [PubMed] [Google Scholar]
  20. Rasmussen H. The calcium messenger system (2). N Engl J Med. 1986 May 1;314(18):1164–1170. doi: 10.1056/NEJM198605013141807. [DOI] [PubMed] [Google Scholar]
  21. Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature. 1983 Feb 17;301(5901):569–574. doi: 10.1038/301569a0. [DOI] [PubMed] [Google Scholar]
  22. Robertson R. M., Wood A. J., Vaughn W. K., Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982 Feb;65(2):281–285. doi: 10.1161/01.cir.65.2.281. [DOI] [PubMed] [Google Scholar]
  23. Ruskoaho H., Toth M., Lang R. E. Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187. Biochem Biophys Res Commun. 1985 Dec 17;133(2):581–588. doi: 10.1016/0006-291x(85)90945-3. [DOI] [PubMed] [Google Scholar]
  24. Sasaguri T., Itoh T., Hirata M., Kitamura K., Kuriyama H. Regulation of coronary artery tone in relation to the activation of signal transductors that regulate calcium homeostasis. J Am Coll Cardiol. 1987 May;9(5):1167–1175. doi: 10.1016/s0735-1097(87)80322-4. [DOI] [PubMed] [Google Scholar]
  25. Savola J. M., Ruskoaho H., Salonen J. S., Puurunen J., Karjalainen A., Kurkela K., Kärki N. T. Cardiovascular and sedative alpha-adrenoceptor effects of detomidine-like arylalkyl imidazoles and associated derivatives. Arzneimittelforschung. 1988 Jan;38(1):29–35. [PubMed] [Google Scholar]
  26. Seamon K. B., Daly J. W. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1986;20:1–150. [PubMed] [Google Scholar]
  27. Spedding M. Interaction of phorbol esters with Ca2+ channels in smooth muscle. Br J Pharmacol. 1987 Jun;91(2):377–384. doi: 10.1111/j.1476-5381.1987.tb10292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sybertz E. J., Baum T., Pula K. K., Nelson S., Eynon E., Sabin C. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):749–758. doi: 10.1097/00005344-198209000-00009. [DOI] [PubMed] [Google Scholar]
  29. Taylor S. H., Silke B., Lee P. S. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N Engl J Med. 1982 Mar 18;306(11):631–635. doi: 10.1056/NEJM198203183061102. [DOI] [PubMed] [Google Scholar]
  30. Vatner D. E., Knight D. R., Homcy C. J., Vatner S. F., Young M. A. Subtypes of beta-adrenergic receptors in bovine coronary arteries. Circ Res. 1986 Oct;59(4):463–473. doi: 10.1161/01.res.59.4.463. [DOI] [PubMed] [Google Scholar]
  31. Vatner S. F., Hintze T. H., Macho P. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog. Circ Res. 1982 Jul;51(1):56–66. doi: 10.1161/01.res.51.1.56. [DOI] [PubMed] [Google Scholar]
  32. Vatner S. F., Hintze T. H. Mechanism of constriction of large coronary arteries by beta-adrenergic receptor blockade. Circ Res. 1983 Sep;53(3):389–400. doi: 10.1161/01.res.53.3.389. [DOI] [PubMed] [Google Scholar]
  33. Yasue H., Omote S., Takizawa A., Nagao M., Miwa K., Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation. 1979 May;59(5):938–948. doi: 10.1161/01.cir.59.5.938. [DOI] [PubMed] [Google Scholar]
  34. Yasue H., Omote S., Takizawa A., Nagao M., Miwa K., Tanaka S. Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol. 1979 Mar;43(3):647–652. doi: 10.1016/0002-9149(79)90026-2. [DOI] [PubMed] [Google Scholar]
  35. Yasue H., Touyama M., Kato H., Tanaka S., Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J. 1976 Feb;91(2):148–155. doi: 10.1016/s0002-8703(76)80568-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES